2f9v
From Proteopedia
Line 1: | Line 1: | ||
[[Image:2f9v.jpg|left|200px]] | [[Image:2f9v.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_2f9v", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | + | --> | |
- | + | {{STRUCTURE_2f9v| PDB=2f9v | SCENE= }} | |
- | + | ||
- | + | ||
- | }} | + | |
'''HCV NS3 protease domain with NS4a peptide and a ketoamide inhibitor with P1 and P2 cyclopropylalannines''' | '''HCV NS3 protease domain with NS4a peptide and a ketoamide inhibitor with P1 and P2 cyclopropylalannines''' | ||
Line 35: | Line 32: | ||
[[Category: Ruan, S.]] | [[Category: Ruan, S.]] | ||
[[Category: Saksena, A.]] | [[Category: Saksena, A.]] | ||
- | [[Category: | + | [[Category: Hcv]] |
- | [[Category: | + | [[Category: Hepatitis c protease]] |
- | [[Category: | + | [[Category: Ketoamide inhibitor]] |
- | [[Category: | + | [[Category: Ns3 protease]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 03:38:32 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 00:38, 4 May 2008
HCV NS3 protease domain with NS4a peptide and a ketoamide inhibitor with P1 and P2 cyclopropylalannines
Overview
Depeptidization efforts of the P(3)-P(2) region of P(3) capped alpha-ketoamide inhibitor of HCV NS3 serine protease 1 are reported. We clearly established that N-methylation of the P(2) nitrogen and modification of the P(2)' carboxylic acid terminus were essential for activity in the replicon assay.
About this Structure
2F9V is a Protein complex structure of sequences from Hepatitis c virus. Full crystallographic information is available from OCA.
Reference
Depeptidization efforts on P3-P2' alpha-ketoamide inhibitors of HCV NS3-4A serine protease: effect on HCV replicon activity., Bogen SL, Ruan S, Liu R, Agrawal S, Pichardo J, Prongay A, Baroudy B, Saksena AK, Girijavallabhan V, Njoroge FG, Bioorg Med Chem Lett. 2006 Mar 15;16(6):1621-7. Epub 2006 Jan 4. PMID:16387495 Page seeded by OCA on Sun May 4 03:38:32 2008